Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ketograce is a nutritional supplement containing a combination of alpha-ketoanalogues and essential amino acids, developed by Biokindle Lifesciences for the management of chronic kidney disease (CKD). The product is designed to provide essential amino acids while minimizing nitrogen intake. By providing nitrogen-free keto-precursors that can be transaminated into their corresponding essential amino acids using nitrogen from non-essential amino acids or urea, it helps reduce the accumulation of nitrogenous waste products in the blood. This metabolic shift helps alleviate uremic symptoms, maintain nutritional status, and potentially delay the progression of renal failure and the need for dialysis in patients with stage 3 to 5 CKD.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alpha-ketoanalogues + essential amino acids.